Works matching AU Rebelatto, Taiane Francieli

Results: 6
    1

    Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 1, p. e2454253, doi. 10.1001/jamanetworkopen.2024.54253
    By:
    • Bastos, Diogo Assed;
    • Soares, Andrey;
    • Schutz, Fabio Augusto Barros;
    • Cronemberger, Eduardo;
    • de Almeida Luz, Murilo;
    • Martins, Suelen Patricia Dos Santos;
    • Muniz, David Queiroz Borges;
    • Cárcano, Flavio Mavignier;
    • Smaletz, Oren;
    • Peixoto, Fábio Affonso;
    • Gomes, Andrea Juliana;
    • Cruz, Felipe Melo;
    • Franke, Fábio André;
    • Herchenhorn, Daniel;
    • Gidekel, Rosemarie;
    • Werutsky, Gustavo;
    • Rebelatto, Taiane Francieli;
    • Gomes de Jesus, Rafaela;
    • Souza, Vinicius Carrera;
    • Fay, André Poisl
    Publication type:
    Article
    2

    Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study.

    Published in:
    Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae220
    By:
    • Monteiro, Fernando Sabino Marques;
    • Junior, Antonio Machado Alencar;
    • Trindade, Karine Martins da;
    • Rebelatto, Taiane Francieli;
    • Maluf, Fernando C;
    • Gazzola, Antonia A;
    • Barrios, Pablo M;
    • Bellmunt, Joaquim;
    • Jesus, Rafaela Gomes de;
    • Silva, Gyl Eanes Barros;
    • Junior, Antonio Augusto Lima Teixeira;
    • Spiess, Philippe E;
    • Fay, Andre P
    Publication type:
    Article
    3
    4

    COLORECTAL CANCER IN YOUNG PATIENTS: A CASE REPORT.

    Published in:
    2016
    By:
    • Rebelatto, Taiane Francieli;
    • Bento, Luiza Haendchen;
    • Salla, Rafaela Fenalti;
    • Ries, Lucas Pires;
    • Almeida, Felipe Augusto;
    • Fior, Barbara Rayanne;
    • Marobin, Roberta;
    • Restelatto, Luciane;
    • Wajner, Simone
    Publication type:
    Case Study
    5

    Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115).

    Published in:
    Breast Cancer Research & Treatment, 2023, v. 198, n. 1, p. 123, doi. 10.1007/s10549-022-06809-8
    By:
    • Maschmann, Raíra Mesquita;
    • De Jesus, Rafaela Gomes;
    • Werutsky, Gustavo;
    • Rebelatto, Taiane Francieli;
    • Queiroz, Geraldo;
    • Simon, Sergio Daniel;
    • Bines, José;
    • Barrios, Carlos Henrique Escosteguy;
    • Rosa, Daniela Dornelles
    Publication type:
    Article
    6

    Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115).

    Published in:
    Breast Cancer Research & Treatment, 2023, v. 197, n. 3, p. 123, doi. 10.1007/s10549-022-06809-8
    By:
    • Maschmann, Raíra Mesquita;
    • De Jesus, Rafaela Gomes;
    • Werutsky, Gustavo;
    • Rebelatto, Taiane Francieli;
    • Queiroz, Geraldo;
    • Simon, Sergio Daniel;
    • Bines, José;
    • Barrios, Carlos Henrique Escosteguy;
    • Rosa, Daniela Dornelles
    Publication type:
    Article